Charles D. Goodwin II - 19 Jan 2022 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role
Chief Executive Officer, Director
Signature
s/ Charles D. Goodwin, II
Issuer symbol
APYX
Transactions as of
19 Jan 2022
Net transactions value
$0
Form type
4
Filing time
31 Jan 2022, 18:11:08 UTC
Next filing
31 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APYX Stock Option (Option to Buy) Award $0 +243,000 $0.000000 243,000 19 Jan 2022 Common Stock 243,000 $10.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.